Potential therapies targeting nuclear metabolic regulation in cancer
MedComm · 2023-12 · 4 (6)
DOI: 10.1002/mco2.421 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 29.11.2023. Verfasst von Yanjie Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology The Third Affiliated Hospital of Chongqing Medical University Chongqing China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 244 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing.
Abstract (Originalsprache)
The interplay between genetic alterations and metabolic dysregulation is increasingly recognized as a pivotal axis in cancer pathogenesis. Both elements are mutually reinforcing, thereby expediting the ontogeny and progression of malignant neoplasms. Intriguingly, recent findings have highlighted the translocation of metabolites and metabolic enzymes from the cytoplasm into the nuclear compartment, where they appear to be intimately associated with tumor cell proliferation. Despite these advancements, significant gaps persist in our understanding of their specific roles within the nuclear milieu, their modulatory effects on gene transcription and cellular proliferation, and the intricacies of their coordination with the genomic landscape. In this comprehensive review, we endeavor to elucidate the regulatory landscape of metabolic signaling within the nuclear domain, namely nuclear metabolic signaling involving metabolites and metabolic enzymes. We explore the roles and molecular mechanisms through which metabolic flux and enzymatic activity impact critical nuclear processes, including epigenetic modulation, DNA damage repair, and gene expression regulation. In conclusion, we underscore the paramount significance of nuclear metabolic signaling in cancer biology and enumerate potential therapeutic targets, associated pharmacological interventions, and implications for clinical applications. Importantly, these emergent findings not only augment our conceptual understanding of tumoral metabolism but also herald the potential for innovative therapeutic paradigms targeting the metabolism–genome transcriptional axis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology The Third Affiliated Hospital of Chongqing Medical University Chongqing China.
- Department of Microbiology and Immunology The Indiana University School of Medicine Indianapolis Indiana USA.
- Department of Radiation Oncology James Comprehensive Cancer Center and College of Medicine at The Ohio State University Columbus Ohio USA.
ORCID-Profile: Chunming Cheng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing
Zitieren
APA
Chen, Y., Xu, J., Liu, X., Guo, L., Yi, P., & Cheng, C. (2023). Potential therapies targeting nuclear metabolic regulation in cancer. MedComm, 4(6). https://doi.org/10.1002/mco2.421
Vancouver
Chen Y, Xu J, Liu X, Guo L, Yi P, Cheng C. Potential therapies targeting nuclear metabolic regulation in cancer. MedComm. 2023;4(6). doi:10.1002/mco2.421
BibTeX
@article{Chen2023,
author = {Chen, Yanjie and Xu, Jie and Liu, Xiaoyi and Guo, Linlin and Yi, Ping and Cheng, Chunming},
title = {Potential therapies targeting nuclear metabolic regulation in cancer},
journal = {MedComm},
year = {2023},
volume = {4},
number = {6},
doi = {10.1002/mco2.421}
}
EUVIMED